Advancing HS Care from Diagnosis to Treatment Selection

Cynthia Trickett, MPAS, PA-C, and Leigh Ann Pansch, MSN, FNP-BC, DCNP, discussed recognizing hidradenitis suppurativa early, screening for comorbidities, and assessing disease burden.

Cynthia Trickett, MPAS, PA-C, and Leigh Ann Pansch, MSN, FNP-BC, DCNP, show how HS immunology supports earlier treatment to prevent tunnels and scarring.

Trickett and Neita compare adalimumab, secukinumab, and bimekizumab trial data and explain how comorbidities guide biologic selection in hidradenitis suppurativa.

Trickett and Neita discuss shared decision-making in HS, investigational ruxolitinib cream and upadacitinib data, and how to counsel on JAK inhibitor boxed warnings.